palbociclib (ibrance) Report issue

Small molecule Approved FDA First in Class Accelerated Approval FDA Priority Review FDA
Back

Drug Pricing Summary

AUS PBS

$152.9183

VA Big4

$413.4724 - $413.7714

VA FSS

$512.3933 - $546.0410

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
palbociclib 100 mg (CAPSULE) $152.9183 AUS PBS generic
  • Ibrance (21)
  • Pfizer Australia Pty Ltd
    palbociclib 100 mg (CAPSULE) $413.6962 VA Big4
  • Ibrance (21)
  • Pfizer, Inc.
    palbociclib 100 mg (CAPSULE) $546.0410 VA FSS
  • Ibrance (21)
  • Pfizer, Inc.
    palbociclib 100 mg (TABLET) $413.6962 VA Big4
  • Ibrance (21)
  • Pfizer, Inc.
    palbociclib 100 mg (TABLET) $512.3933 VA FSS
  • Ibrance (21)
  • Pfizer, Inc.
    palbociclib 125 mg (CAPSULE) $152.9183 AUS PBS generic
  • Ibrance (21)
  • Pfizer Australia Pty Ltd
    palbociclib 125 mg (CAPSULE) $413.4724 VA Big4
  • Ibrance (21)
  • Pfizer, Inc.
    palbociclib 125 mg (CAPSULE) $546.0410 VA FSS
  • Ibrance (21)
  • Pfizer, Inc.
    palbociclib 125 mg (TABLET) $413.4724 VA Big4
  • Ibrance (21)
  • Pfizer, Inc.
    palbociclib 125 mg (TABLET) $512.3933 VA FSS
  • Ibrance (21)
  • Pfizer, Inc.
    palbociclib 75 mg (CAPSULE) $152.9183 AUS PBS generic
  • Ibrance (21)
  • Pfizer Australia Pty Ltd
    palbociclib 75 mg (CAPSULE) $413.7714 VA Big4
  • Ibrance (21)
  • Pfizer, Inc.
    palbociclib 75 mg (CAPSULE) $546.0410 VA FSS
  • Ibrance (21)
  • Pfizer, Inc.
    palbociclib 75 mg (TABLET) $413.7714 VA Big4
  • Ibrance (21)
  • Pfizer, Inc.
    palbociclib 75 mg (TABLET) $512.3933 VA FSS
  • Ibrance (21)
  • Pfizer, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue